FIA
NVNO

FNY Investment Advisers’s enVVeno Medical NVNO Stock Holding History

FNY Investment Advisers’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6
Closed -$4K – 991
2019
Q3 		$4K Hold
6
– – ﹤0.01% 670
2019
Q2 		$5K Hold
6
– – ﹤0.01% 699
2019
Q1 		$7K Hold
6
– – ﹤0.01% 485
2018
Q4 		$7K Buy
+6
New +$10.8K ﹤0.01% 520

Other funds holding NVNO

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FNY Investment Advisers's NVNO Position: Q4 2019 in Review

FNY Investment Advisers sold out of enVVeno Medical (NVNO) in Q4 2019, closing a stake of 6 shares — an estimated $4K sold.

FNY Investment Advisers first reported a position in NVNO in Q4 2018 and held it in 4 quarters. The position peaked at $7K in Q1 2019. 6 funds tracked by Wall St. Rank hold NVNO as of Q4 2019.

  • FNY Investment Advisers reported no remaining enVVeno Medical position as of Q4 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 6 enVVeno Medical shares in Q4 2019, an estimated $4K.
  • FNY Investment Advisers first reported a position in enVVeno Medical in Q4 2018 and held it in 4 quarters.
  • FNY Investment Advisers's enVVeno Medical position peaked at $7K in Q1 2019.
  • 6 funds tracked by Wall St. Rank held enVVeno Medical as of Q4 2019.

Based on FNY Investment Advisers's 13F filing for Q4 2019, filed 10 Jan 2020.